Bio Protocol Launches Aubrai on Base Network
- Aubrai launched on the Base network with Bio Protocol, VitaDAO.
- Initial market cap reached $7-$9 million briefly.
- Oversubscription signals high community interest in DeSci projects.
Bio Protocol’s first BioAgent Launch project, Aubrai, has been announced on the Base network, marking a collaboration with VitaDAO and longevity expert Dr. Aubrey de Grey.
The launch highlights a significant shift in decentralized science, integrating AI research with blockchain funding, drawing heightened community interest and substantial financial backing.
Bio Protocol’s Aubrai project has officially launched on the Base network, backed by collaborative efforts including Bio Protocol, VitaDAO, and contributions from longevity expert Dr. Aubrey de Grey. The launch marks a key achievement in decentralized science (DeSci) by effectively blending AI-driven research with blockchain-backed funding mechanisms, potentially reshaping traditional research funding methods.
The consequences of traditional financing are a chronic funding gap, over-reliance on philanthropy, and a ‘valley of death’ between discovery and the clinic. That’s why we champion alternative mechanisms – DAOs, longevity-focused venture funds, and DeSci platforms – which can tolerate long horizons, align incentives around societal benefit, and crowd-source risk. — Aubrey de Grey, Founder, LEV Foundation
Community support was evident during Aubrai’s Ignition Sale, oversubscribed by 13.5 times. Initial trading volume reached $6.4 million within hours, indicating robust engagement and interest. The sale, setting an initial target of 234,000 BIO, showcased the potential for decentralized systems to attract substantial funding, supporting innovative scientific endeavors.
Bio Protocol and Aubrai tokens showed notable price fluctuations, peaking temporarily over $20 million, demonstrating strong initial market reactions. Aubrai’s model introduces token holders as stakeholders in research project outcomes, emphasizing potential shifts in research governance and commercial opportunities for future scientific discovery Kickstarter platforms.
